# A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy Humans

> **NCT01981928** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Europe B.V.** · enrollment: 48 (actual)

## Conditions studied

- Safety
- Tolerability
- Pharmacokinetics of ASP7962

## Interventions

- **DRUG:** ASP7962
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01981928
- **Lead sponsor:** Astellas Pharma Europe B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2014-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01981928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01981928, "A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy Humans". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01981928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*